Skip to main content
Clinical Trials/NCT01393028
NCT01393028TerminatedNot Applicable

Computed Tomography Versus Exercise Testing in Suspected Coronary Artery Disease

Erasmus Medical Center4 sites in 1 country350 target enrollmentStarted: July 1, 2011Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Terminated
Enrollment
350
Locations
4
Primary Endpoint
Chest pain

Study Overview

Brief Summary

Direct non-invasive coronary imaging by computed tomography (CT) has the potential to improve the workup of patients with stable chest pain complaints. The objective of the study is to compare in a randomized fashion the effectiveness and efficiency of a CT angiographic driven workup of suspected coronary artery disease in comparison to the standard workup using stress testing.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Diagnostic
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Men and women aged >18 years.
  • Stable symptoms of chest pain or dyspnea potentially caused by obstructive CAD.

Exclusion Criteria

  • A history of surgical or percutaneous coronary revascularization
  • Non-revascularized angiographic obstructive coronary artery disease (>50% diameter reduction).
  • Normal invasive coronary angiography or stress imaging less than 1 years ago.
  • Inability or unwillingness to provide informed consent.

Arms & Interventions

Cardiac CT

Experimental

Cardiac CT (CT calcium and/or CT angiography), followed by stress testing, invasive angiography or neither depending on the CT scan result

Intervention: Cardiac CT (Other)

Standard care

Other

Standard diagnostic management, including stress testing and/or invasive angiography

Intervention: Standard care (Other)

Outcomes

Primary Outcomes

Chest pain

Time Frame: 1 year

Reduction of chest pain symptoms by standardized questionnaire, at one year follow-up

Class IA Revascularizations

Time Frame: 1 year

Number of revascularizations with an ESC class 1A indication

Secondary Outcomes

  • Cost-effectiveness(1 year)
  • Major adverse cardiovascular events(1 year)
  • Overall medical expenses(1 year)
  • Radiation dose(1 year)
  • Quality of life(1 year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Koen Nieman

Dr K Nieman

Erasmus Medical Center

Study Sites (4)

Loading locations...

Similar Trials